Articles:

List of Speakers

Cancer Res 1982 42: 3267s [PDF]  

Introduction to the Conference, Aromatase: New Perspectives for Breast Cancer

Richard J. Santen
Cancer Res 1982 42: 3268s [PDF]  

Review of Studies on Estrogen Biosynthesis in the Human

Pentti K. Siiteri
Cancer Res 1982 42: 3269s-3273s. [Abstract] [PDF]  

Physiology, Biochemistry, and Biological Significance:

Aromatase in the Central Nervous System

F. Naftolin and Neil J. MacLusky
Cancer Res 1982 42: 3274s-3276s. [Abstract] [PDF]  

Biochemical Mechanism of Aromatization

Jack Fishman
Cancer Res 1982 42: 3277s-3279s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3279s-3280s. [PDF]  

Epidemiological Considerations: Aromatase, Obesity, and Breast Carcinoma:

Obesity, Androgens, Estrogens, and Cancer Risk

M. A. Kirschner, G. Schneider, N. H. Ertel, and E. Worton
Cancer Res 1982 42: 3281s-3285s. [Abstract] [PDF]  

Cyclic Ovarian Function and Breast Cancer

Barry M. Sherman, Robert B. Wallace, and Judy A. Bean
Cancer Res 1982 42: 3286s-3288s. [Abstract] [PDF]  

Relationship of Obesity to Blood Estrogens

Barnett Zumoff
Cancer Res 1982 42: 3289s-3292s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3292s-3294s. [PDF]  

In Vitro and in Vivo Assay Methodology and Biochemistry:

In Vitro Assays of Aromatase and Their Role in Studies of Estrogen Formation in Target Tissues

Judith Weisz
Cancer Res 1982 42: 3295s-3298s. [Abstract] [PDF]  

Multiple Forms of Aromatase and Response of Breast Cancer Aromatase to Antiplacental Aromatase II Antibodies

Yoshio Osawa, Buichi Tochigi, Tadayoshi Higashiyama, Carol Yarborough, Tohoru Nakamura, and Takara Yamamoto
Cancer Res 1982 42: 3299s-3305s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3305s-3306s. [PDF]  

Pharmacological Inhibitors of Aromatase: Biochemical Studies:

Methods and Results of Aromatization Studies in Vivo

Christopher Longcope
Cancer Res 1982 42: 3307s-3311s. [Abstract] [PDF]  

Overview of Recent Development of Aromatase Inhibitors

Angela M. H. Brodie
Cancer Res 1982 42: 3312s-3314s. [Abstract] [PDF]  

Basic Studies on Aminoglutethimide

Hilton A. Salhanick
Cancer Res 1982 42: 3315s-3321s. [Abstract] [PDF]  

Design of Mechanism-based Inactivators of Human Placental Aromatase

Patrick A. Marcotte and Cecil H. Robinson
Cancer Res 1982 42: 3322s-3326s. [Abstract] [PDF]  

A New Hypothesis Based on Suicide Substrate Inhibitor Studies for the Mechanism of Action of Aromatase

Douglas F. Covey and William F. Hood
Cancer Res 1982 42: 3327s-3332s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3332s-3333s. [PDF]  

Substituted C₁₉ Steroid Analogs as Inhibitors of Aromatase

Robert W. Brueggemeier, Catherine E. Snider, and Raymond E. Counsell
Cancer Res 1982 42: 3334s-3337s. [Abstract] [PDF]  

Estrogen Synthesis in Human Breast Tumor and Its Inhibition by Testololactone and Bromoandrostenedione

Thomas L. Dao
Cancer Res 1982 42: 3338s-3341s. [Abstract] [PDF]  

Biochemistry of Aromatase: Significance to Female Reproductive Physiology

Kenneth J. Ryan
Cancer Res 1982 42: 3342s-3344s. [Abstract] [PDF]  

Pharmacological Inhibitors of Aromatase: In Vivo Studies:

In Vivo Effects of ¹-Testololactone on Peripheral Aromatization

Howard L. Judd, Robert M. Barone, Larry R. Laufer, Joseph C. Gambone, Steven L. Monfort, and Bill L. Lasley
Cancer Res 1982 42: 3345s-3348s. [Abstract] [PDF]  

Steroid Hormone Profiles in Women Treated with Aminoglutethimide for Metastatic Carcinoma of the Breast

E. Samojlik, R. J. Santen, M. A. Kirschner, and N. H. Ertel
Cancer Res 1982 42: 3349s-3352s. [Abstract] [PDF]  

In Vivo and in Vitro Pharmacological Studies of Aminoglutethimide as an Aromatase Inhibitor

R. J. Santen, S. J. Santner, N. Tilsen-Mallett, H. R. Rosen, E. Samojlik, and J. D. Veidhuis
Cancer Res 1982 42: 3353s-3357s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3357s-3359s. [PDF]  

Aromatase Inhibitors as Treatment of Animal Breast Carcinoma Models:

Effects of Aromatase Inhibitor 4-Hydroxyandrostenedione and Other Compounds in the 7,12-Dimethylbenz(a)anthracene-induced Breast Carcinoma Model

Angela M. H. Brodie, Wesley M. Garrett, James R. Hendrickson, and Chon-Hwa Tsai-Morris
Cancer Res 1982 42: 3360s-3363s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3363s-3364s. [PDF]  

Aromatase in Human Breast Carcinoma[mdash ]Biochemistry: In Vitro Inhibitors:

Significance of Aromatase Activity in Human Breast Cancer

W. R. Miller, R. A. Hawkins, and A. P. M. Forrest
Cancer Res 1982 42: 3365s-3368s. [Abstract] [PDF]  

Aromatase in Human Breast Carcinoma

M. E. Blackstein and D. W. Killinger
Cancer Res 1982 42: 3369s-3372s. [Abstract] [PDF]  

Comparative Studies of Aromatase Inhibitors in Relation to the Significance of Estrogen Synthesis in Human Mammary Tumors

Yusuf J. Abul-Hajj
Cancer Res 1982 42: 3373s-3377s. [Abstract] [PDF]  

Comparative Studies of Aromatase Inhibitors in Cultured Human Breast Cancer Cells

J. H. MacIndoe, G. R. Woods, L. A. Etre, and D. F. Covey
Cancer Res 1982 42: 3378s-3381s. [Abstract] [PDF]  

A Reassessment of the Role of Breast Tumor Aromatization

H. Leon Bradlow
Cancer Res 1982 42: 3382s-3384s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3385s-3386s. [PDF]  

Aromatase Inhibitors as Treatment of Human Breast Carcinoma:

¹-Testololactone: Clinical Trials

Albert Segaloff
Cancer Res 1982 42: 3387s-3388s. [Abstract] [PDF]  

Treatment of Advanced Breast Cancer with Aminoglutethimide: A 14-Year Experience

Kenneth E. Gale
Cancer Res 1982 42: 3389s-3396s. [Abstract] [PDF]  

Adequacy of Estrogen Suppression with Aminoglutethimide and Hydrocortisone as Treatment of Human Breast Cancer: Correlation of Hormonal Data with Clinical Responses

Richard J. Santen, Thomas, J. Worgul, Eugeniusz Samojlik, Alice E. Boucher, Allan Lipton, and Harold Harvey
Cancer Res 1982 42: 3397s-3401s. [Abstract] [PDF]  

Aminoglutethimide in the Treatment of Metastatic Breast Cancer

Michael B. Troner
Cancer Res 1982 42: 3402s-3404s. [Abstract] [PDF]  

Aminoglutethimide in the Treatment of Advanced Postmenopausal Breast Cancer

Adrian L. Harris, Trevor J. Powles, and Ian E. Smith
Cancer Res 1982 42: 3405s-3408s. [Abstract] [PDF]  

Tamoxifen and Aminoglutethimide in Advanced Breast Cancer

Joseph Corkey, Robert C. F. Leonard, Craig Henderson, Rebecca S. Gelman, Joseph Hourihan, Diane M. Ascoli, and Hilton A. Salhanick
Cancer Res 1982 42: 3409s-3414s. [Abstract] [PDF]  

Adjuvant Aminoglutethimide Therapy for Postmenopausal Patients with Primary Breast Cancer: Progress Report

R. Charles Coombes, Clair Chilvers, Mitch Dowsett, Jean-Claude Gazet, Hubert T. Ford, Radka Bettelheim, Caroline Gordon, Ian E. Smith, David Zava, Trevor J. Powles, and Investigators of the Collaborative Breast Cancer Project
Cancer Res 1982 42: 3415s-3418s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3418s-3419s. [PDF]  

Antiestrogens as Alternative Means of Inhibiting Estrogen Action:

New Strategies for Investigating Antiestrogen Action in Breast Cancer

William Leo McGuire
Cancer Res 1982 42: 3420s-3422s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3422s-3423s. [PDF]  

Antiestrogen Treatment of Breast Cancer: An Overview

Olof H. Pearson, Andrea Manni, and Baha'uddin M. Arafah
Cancer Res 1982 42: 3424s-3428s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3428s-3429s. [PDF]  

Tamoxifen versus Aminoglutethimide versus Combined Tamoxifen and Aminoglutethimide in the Treatment of Advanced Breast Carcinoma

Ian E. Smith, Adrian L. Harris, Michael Morgan, Jean-Claude Gazet, and J. Alan McKinna
Cancer Res 1982 42: 3430s-3432s. [Abstract] [PDF]  

Randomized Trials of Aromatase Inhibitors versus Antiestrogens:

Discussion

Cancer Res 1982 42: 3433s [PDF]  

Randomized Trial of Aminoglutethimide versus Tamoxifen in Metastatic Breast Cancer

Allan Lipton, Harold A. Harvey, Richard J. Santen, Alice Boucher, Deborah White, Albert Bernath, Richard Dixon, George Richards, and Ahmed Shafik
Cancer Res 1982 42: 3434s-3436s. [Abstract] [PDF]  

Aminoglutetehimide in Tamoxifen-resistant Patients: The Melbourne Experience

Robin M. L. Murray
Cancer Res 1982 42: 3437s-3438s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3439s-3441s. [PDF]  

Phase II Study of Aminoglutethimide and Medroxyprogesterone Acetate in the Treatment of Patients with Advanced Breast Cancer

Gerd A. Nagel, Hans-Erik Wander, and Hans-Christian Biossey
Cancer Res 1982 42: 3442s-3444s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3444s [PDF]  

Use of Aminoglutethimide as Second-Line Endocrine Therapy in Metastatic Breast Cancer

Stanley B. Kaye, Robert L. Woods, Richard M. Fox, Alan S. Coates, and Martin H. N. Tattersall
Cancer Res 1982 42: 3445s-3447s. [Abstract] [PDF]  

Aminoglutethimide in Tamoxifen-resistant Patients:

Aminoglutethimide after Tamoxifen Therapy in Advanced Breast Cancer: M. D. Anderson Hospital Experience

Aman U. Buzdar, Kimberly C. Powell, and Geroge R. Blumenschein
Cancer Res 1982 42: 3448s-3450s. [Abstract] [PDF]  

Cross-Over Comparison of Tamoxifen and Aminoglutethimide in Advanced Breast Cancer

Harold A. Harvey, Allan Lipton, Deborah S. White, Richard J. Santen, Alice E. Boucher, Ahmed S. Shafik, Richard J. Dixon, and Members of The Central Pennsylvania Oncology Group
Cancer Res 1982 42: 3451s-3453s. [Abstract] [PDF]  

Aromatase Inhibition versus Surgical Ablation:

Comparison of Surgical Adrenalectomy to Medical Adrenalectomy in Patients with Metastatic Carcinoma of the Breast

Samuel A. Wells, Jr., Thomas J. Worgul, Eugeniusz Samojlik, Alice E. Boucher, Allan Lipton, Deborah White, Emma Smart, Charles Cox, and Richard J. Santen
Cancer Res 1982 42: 3454s-3457s. [Abstract] [PDF]  

Clinical Trial of Multiple Endocrine Therapy for Metastatic and Locally Advanced Breast Cancer with Tamoxifen-Aminoglutethimide-Danazol Compared to Tamoxifen Used Alone

Trevor J. Powles, C. Gordon, and R. C. Coombes
Cancer Res 1982 42: 3458s-3460s. [Abstract] [PDF]  

Combinations of Agents to Inhibit Estrogenic Actions as Treatment of Breast Carcinoma:

Progress Report on Two Clinical Trials in Women with Advanced Breast Cancer. Trial I: Tamoxifen versus Tamoxifen plus Aminoglutethimide; Trial II: Aminoglutethimide in Patients with Prior Tamoxifen Exposure

James N. Ingle, Stephanie J. Green, David L. Ahmann, John H. Edmonson, William C. Nichols, Stephen Frytak, and Joseph Rubin
Cancer Res 1982 42: 3461s-3464s. [Abstract] [PDF]  

Discussion

Cancer Res 1982 42: 3464s-3467s. [PDF]  

Closing Remarks to the Conference, Aromatase: New Perspectives for Breast Cancer

Allan Lipton, Harold A. Harvey, and Richard J. Santen
Cancer Res 1982 42: 3468s [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.